BNXTF (BioNxt Solutions) Tariff Resilience Score: 5/10 (As of Aug. 13, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BNXTF BioNxt Solutions Inc BNXTF
24 GF Score
Price $0.23
! 4 Warning Signs
View Full Analysis

What is BioNxt Solutions Tariff Resilience Score?

BioNxt Solutions BNXTF +2.87% 24 Tariff Resilience Score is 5 as of Aug. 13, 2026. GuruFocus rates BNXTF with a GF Score™ of 24/100. The stock has 4 warning signs investors should review. Among 1,024 Drug Manufacturers companies, BioNxt Solutions ranks better than 84.37% on this metric.

BioNxt Solutions has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

BioNxt Solutions has BioNxt Solutions, involved in biotech, faces moderate tariff risks. While the industry enjoys some exemptions, the company's reliance on international supply chains for research materials exposes it to potential cost increases. Mitigation is possible through supplier diversification.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes BioNxt Solutions might have Average Resilient.

BioNxt Solutions  (OTCPK:BNXTF) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

BioNxt Solutions Tariff Resilience Score Related Terms

BNXTF vs ZTS: Tariff Resilience Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, BioNxt Solutions's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioNxt Solutions Tariff Resilience Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioNxt Solutions's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where BioNxt Solutions's Tariff Resilience Score falls into.


BNXTF
24GF Score
BioNxt Solutions Inc BNXTF
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 5 mean?
BioNxt Solutions (BNXTF) has a Tariff Resilience Score of 5 as of Aug. 13, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, BioNxt Solutions ranks #160 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 15.6%.
Is BioNxt Solutions' Tariff Resilience Score too high?
BioNxt Solutions' current Tariff Resilience Score is 5. Based on the distribution chart, BioNxt Solutions ranks #160 out of 1024 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, BioNxt Solutions has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does BioNxt Solutions' Tariff Resilience Score compare to ZTS?
According to the Drug Manufacturers industry distribution chart, BioNxt Solutions ranks #160 out of 1024 companies for Tariff Resilience Score. This places BioNxt Solutions in the top 16% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Drug Manufacturers company?
A good Tariff Resilience Score depends on the Drug Manufacturers industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. BioNxt Solutions's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioNxt Solutions stock overvalued right now?
BioNxt Solutions (BNXTF) has a current Tariff Resilience Score of 5. The current Tariff Resilience Score is 5. BioNxt Solutions' overall GF Score™ is 24/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For BioNxt Solutions (BNXTF), the current Tariff Resilience Score is 5 as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioNxt Solutions Business Description

Other Exchanges BXT:GermanyBNXT:Canada
Address 1928 Linden Road, Vancouver, BC, CAN, V6M 1E7
BioNxt Solutions Inc is is a bioscience innovator focused on next-generation drug delivery systems. With research and development operations in North America and Europe, BioNxt is advancing regulatory approvals and commercialization efforts, focused on European markets. The company is committed to improving healthcare by delivering precise, patient-centric solutions that enhance treatment outcomes. Its pipeline includes BNT23001, BNT23002, BNT24002, BNT24003, BNT24004. Its geographic areas are Austria, Germany, Switzerland regions.
24GF Score

Get the complete analysis for BNXTF

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.23
Price